ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: chemotherapy in patients with neuroendocrine tumors.
about
The pivotal role of mammalian target of rapamycin inhibition in the treatment of patients with neuroendocrine tumorsGastroenteropancreatic high-grade neuroendocrine carcinomaIrinotecan plus cisplatin followed by octreotide long-acting release maintenance treatment in advanced gastroenteropancreatic neuroendocrine carcinoma: IPO-NEC study.Update on pancreatic neuroendocrine tumors.Clinical results of radionuclide therapy of neuroendocrine tumours with 90Y-DOTATATE and tandem 90Y/177Lu-DOTATATE: which is a better therapy option?Inverse expression of somatostatin and CXCR4 chemokine receptors in gastroenteropancreatic neuroendocrine neoplasms of different malignancyThe joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumoursTherapy of metastatic pancreatic neuroendocrine tumors (pNETs): recent insights and advancesIncidence, patterns of care and prognostic factors for outcome of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): results from the National Cancer Registry of Spain (RGETNE).Preclinical assesement of survivin and XIAP as prognostic biomarkers and therapeutic targets in gastroenteropancreatic neuroendocrine neoplasia.Nordic Guidelines 2010 for diagnosis and treatment of gastroenteropancreatic neuroendocrine tumours.Care for patients with multiple endocrine neoplasia type 1: the current evidence base.Neuroendocrine neoplasms of the gastrointestinal tractNew therapeutic options for metastatic malignant insulinomas.Novel molecular targets for the treatment of gastroenteropancreatic endocrine tumors: answers and unsolved problemsPharmacokinetics and pharmacodynamics of sunitinib for the treatment of advanced pancreatic neuroendocrine tumors.Advancements in pancreatic neuroendocrine tumors.Spinal cord compression after radiolabeled metaiodobenzylguanidine analogue therapy in advanced malignant insulinoma.The treatment of hyperinsulinemic hypoglycaemia in adults: an update.Cross sectional and nuclear medicine imaging of pancreatic insulinomas.Sunitinib in advanced pancreatic neuroendocrine tumors: latest evidence and clinical potentialManagement of the hormonal syndrome of neuroendocrine tumors.Prolonged clinical benefit of everolimus therapy in the management of high-grade pancreatic neuroendocrine carcinoma."Cherry picking", a multiple non-anatomic liver resection technique, as a promising option for diffuse liver metastases in patients with neuroendocrine tumours.Neuroendocrine tumors diagnosed at the Antonio Cardarelli hospital (Naples, Italy) between 2006-2009: a single-institution analysis.Surgical treatment of pancreatic endocrine tumours in Italy: results of a prospective multicentre study of 262 cases
P2860
Q26740374-27D50781-5FC1-45DE-B7D6-ABA2B926F811Q26998392-0F9602DF-B110-4AE8-87B7-2768766A8515Q33648996-0AA5906E-1805-49D3-A9F7-7D1E16FA88DDQ34453043-A42BA614-9E6B-45FD-AC95-62E0AAC917FCQ35201583-9BE9AC7A-4715-42BC-958E-A6EC28DC0561Q36413831-412AC606-A686-4DB1-A283-23E0D8DDE575Q36755905-15C22480-3A04-40BE-8BDB-DDE2F0C818EAQ37125550-0277D21B-5B3E-4827-A608-47E2268131B3Q37688704-B691EF24-A1EA-4F0F-9B11-B8D6D70233F8Q37702716-4C5BDA02-3EEB-41F7-B033-EFB98B7769E5Q37765569-BC25A5E7-0879-4B86-AD9A-09722AEE3D55Q37808142-F9EE9D93-78C0-461E-92AF-FAA3CE5BCE08Q37883066-3EA57360-9E23-43C8-B6F4-8024CF846D26Q37886036-38D23650-28BF-4441-8BF6-BC5D545127DEQ38076275-7B58C91F-4373-4296-A75F-78A78004374AQ38099390-56561E3E-DA9A-4A98-A286-FB9C898DF96BQ38125257-1D25CF71-22C7-497C-89B1-70EFF06AAB31Q38494154-4770B107-29B8-492B-A947-E25F87F7ADA8Q38953515-B06EA18A-80C9-4D2D-BA5F-D92D7DC241B3Q38957569-573649FF-409A-4EB4-99D4-D1B93B1A0F31Q39952447-F15A8F6A-FFA5-4A76-AA5F-02902C5B1969Q41832570-BD3AA520-186C-4451-AF3F-721F68D2F778Q42588070-C01EDE4C-1D55-41B9-9602-2966D506BE9CQ43475328-6E738479-A8ED-452A-AE8F-28F6A67AECF4Q44846366-69875D9B-1CB3-4B9A-9921-95872A007B86Q57820051-B3B04771-45ED-4D47-80D9-E6C83F798451
P2860
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: chemotherapy in patients with neuroendocrine tumors.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 28 August 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
ENETS Consensus Guidelines for ...... ts with neuroendocrine tumors.
@en
ENETS Consensus Guidelines for ...... ts with neuroendocrine tumors.
@nl
type
label
ENETS Consensus Guidelines for ...... ts with neuroendocrine tumors.
@en
ENETS Consensus Guidelines for ...... ts with neuroendocrine tumors.
@nl
prefLabel
ENETS Consensus Guidelines for ...... ts with neuroendocrine tumors.
@en
ENETS Consensus Guidelines for ...... ts with neuroendocrine tumors.
@nl
P2093
P921
P356
P1433
P1476
ENETS Consensus Guidelines for ...... ts with neuroendocrine tumors.
@en
P2093
Barbro Eriksson
Emilio Bajetta
Emmanuel Mitry
European Neuroendocrine Tumor Society
Mallorca Consensus Conference participants
Marco Platania
Marianne Pavel
Ramon Salazar
Ursula Plöckinger
P304
P356
10.1159/000225950
P577
2009-08-28T00:00:00Z